Opinion: My brother can’t access a just-approved breakthrough drug for his rare disease

Rare disease clinical trials, policy discussions, and advocacy initiatives often leave adults behind.
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

Rare disease clinical trials, policy discussions, and advocacy initiatives often leave adults behind.
Source
Stat News
Opens original article in a new tab

An experimental Medicare program, how family dynamics affect brain recovery, and other health news from Morning Rounds

The director of WHO's Eastern Mediterranean region is weighing whether to run to be the next director-general at a time of tumult over Iran and beyond.

Former Sen. Ben Sasse gives a glimpse of what it's like to be a participant in an tough but promising new drug for pancreatic cancer.

Dana-Farber CEO Benjamin Ebert has no shortage of ideas and vision for the cancer institute as it untangles from Mass General Brigham and builds a new hospital.